ABCA1 and lung cancer: Indeed, in lung cancer cells, simvastatin remodels TME and reverses epithelial-mesenchymal transition (EMT) by re-polarizing tumor-associated macrophages (TAMs) from M2 to M1 via cholesterol-associated LXR/ABCA1 regulation (Jin et al., 2019).